To say ‘Sleeping Giant’ about Poland is no longer true claims Wojciech Przybys, VP EMEA and provides a deeper analysis of the polish clinical research market in an interview for Focus Report published in Pharmaceutical Executive this August. Poland, being an important and still growing market for drug development, is most importantly the biggest country in the region as its market share reaches 18%of clinical trials. Wojciech expresses a high level of optimism with regards to the future of the industry in Poland. The country provides excellent quality data, has initiated structured cooperation among stakeholders on the market and became a partner expert sharing knowledge and expertise to shape clinical trial environment.
Read more of the analysis of the Polish Clinical trial market.